This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Amgen Inc.. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Christopher W. Spancake: Innovator in Injectable Formulations
Introduction
Christopher W. Spancake is a notable inventor based in Cary, NC (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of stable emulsion formulations. His work focuses on improving the safety and efficacy of injectable medications.
Latest Patents
Christopher W. Spancake holds a patent for "Stable emulsion formulations." This invention relates to injectable formulations of irritant agents, such as calcimimetics, that are pharmaceutically stable. The formulations demonstrate a reduced incidence of irritation, pain, phlebitis, precipitation, and hemolysis upon injection. This innovation is crucial for enhancing patient comfort and treatment outcomes.
Career Highlights
Christopher is currently employed at Amgen Inc., a leading biotechnology company known for its focus on innovative therapies. His work at Amgen has allowed him to contribute to advancements in drug formulation and delivery systems. With a patent portfolio that includes 1 patent, he continues to push the boundaries of pharmaceutical science.
Collaborations
Throughout his career, Christopher has collaborated with talented professionals, including Seshadri Neervannan and Anne Navratil. These collaborations have fostered a creative environment that encourages innovation and the development of new solutions in the pharmaceutical industry.
Conclusion
Christopher W. Spancake is a dedicated inventor whose work in stable emulsion formulations has the potential to significantly improve patient care. His contributions to the field of pharmaceuticals exemplify the importance of innovation in healthcare.